Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Robert  Paarlberg, MS

Robert Paarlberg, MS

Principal

Paarlberg & Associates LLC, United States

Learning Objective : Recognize the recent events that are shaping the disclosure landscape; Evaluate how one company’s announcement to provide open access to data tables may influence clinical research; Assess how trial sponsors are preparing for disclosure of patient-level data, lay summaries and unredacted CSRs.

Speaker(s)

Rebecca  Li, PHD

Panelist

Rebecca Li, PHD

Vivli , United States

Executive Director, Center for Global Clinical Research Data

Jacqueline  Cole, MS

Panelist

Jacqueline Cole, MS

Eli Lilly and Company, United States

Oncology Clinical Operations Portfolio Management, NA Clinical Operations

Jessica S. Scott, JD, MD

Panelist

Jessica S. Scott, JD, MD

Legacy Health Strategies , United States

President

Robert  Paarlberg, MS

Panelist

Robert Paarlberg, MS

Paarlberg & Associates LLC, United States

Principal

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.